Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

Finasteride may help improve certain brain function issues linked to dopamine.

Blocking a specific enzyme in male rat fetuses leads to the development of nipples and feminized genitalia.

Equisetum debile extract, especially the ethyl acetate type, may be a promising natural ingredient for anti-hair loss products.

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

Isolation stress in rats reduces brain enzyme levels, affecting dopamine function.

Finasteride, a drug, can block the seizure-preventing effects of a hormone called progesterone in mice.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

The study found that the enzyme linked to acne is present in the same areas of both acne-affected and normal skin.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Cortisone reductase deficiency can cause high androgen and cortisol levels and may be missed in women with similar symptoms.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.